Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Extremely Premature | 7 | 2025 | 112 | 2.570 |
Why?
|
| Xylitol | 2 | 2025 | 8 | 1.810 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2023 | 178 | 1.710 |
Why?
|
| Premature Birth | 3 | 2025 | 421 | 1.710 |
Why?
|
| Zika Virus Infection | 5 | 2019 | 175 | 1.560 |
Why?
|
| Child Development | 4 | 2025 | 269 | 1.300 |
Why?
|
| Infant, Newborn | 25 | 2025 | 8518 | 1.270 |
Why?
|
| Global Health | 5 | 2025 | 634 | 1.210 |
Why?
|
| Developmental Disabilities | 2 | 2025 | 776 | 1.200 |
Why?
|
| Zika Virus | 4 | 2019 | 153 | 1.170 |
Why?
|
| Milk, Human | 4 | 2024 | 318 | 1.150 |
Why?
|
| Infant Health | 2 | 2019 | 16 | 1.150 |
Why?
|
| Chewing Gum | 2 | 2025 | 13 | 1.110 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2020 | 499 | 1.050 |
Why?
|
| Birth Weight | 2 | 2025 | 345 | 1.000 |
Why?
|
| Weight Loss | 4 | 2025 | 530 | 0.970 |
Why?
|
| Enterocolitis, Necrotizing | 3 | 2025 | 254 | 0.940 |
Why?
|
| Microbiota | 3 | 2019 | 435 | 0.880 |
Why?
|
| Sweetening Agents | 1 | 2024 | 37 | 0.860 |
Why?
|
| Periodontal Diseases | 1 | 2024 | 31 | 0.860 |
Why?
|
| Patient Care Bundles | 1 | 2023 | 21 | 0.790 |
Why?
|
| Body Fluids | 1 | 2023 | 45 | 0.790 |
Why?
|
| Weight Gain | 1 | 2025 | 382 | 0.770 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2024 | 172 | 0.760 |
Why?
|
| Bioethics | 1 | 2024 | 81 | 0.750 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2020 | 261 | 0.690 |
Why?
|
| Pregnancy | 12 | 2025 | 7407 | 0.670 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 44 | 0.650 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 145 | 0.630 |
Why?
|
| Health Resources | 1 | 2021 | 127 | 0.610 |
Why?
|
| Mentoring | 1 | 2021 | 84 | 0.590 |
Why?
|
| Mentors | 1 | 2021 | 168 | 0.590 |
Why?
|
| Infant, Premature | 4 | 2025 | 853 | 0.570 |
Why?
|
| Malawi | 3 | 2025 | 338 | 0.560 |
Why?
|
| Microcephaly | 4 | 2019 | 350 | 0.560 |
Why?
|
| Mothers | 1 | 2021 | 374 | 0.550 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 540 | 0.550 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 333 | 0.550 |
Why?
|
| Metagenome | 1 | 2019 | 139 | 0.550 |
Why?
|
| Metagenomics | 1 | 2019 | 115 | 0.550 |
Why?
|
| Maternal Health | 1 | 2018 | 28 | 0.540 |
Why?
|
| Patient Discharge | 1 | 2021 | 510 | 0.520 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 831 | 0.510 |
Why?
|
| Growth Disorders | 1 | 2018 | 183 | 0.510 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 104 | 0.460 |
Why?
|
| Prenatal Care | 3 | 2024 | 346 | 0.450 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2014 | 70 | 0.420 |
Why?
|
| Female | 20 | 2025 | 70388 | 0.420 |
Why?
|
| Humans | 30 | 2025 | 130483 | 0.420 |
Why?
|
| Fetal Diseases | 1 | 2018 | 440 | 0.410 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 322 | 0.380 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 159 | 0.380 |
Why?
|
| Gestational Age | 4 | 2025 | 1209 | 0.360 |
Why?
|
| Internship and Residency | 1 | 2021 | 1217 | 0.320 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2021 | 343 | 0.270 |
Why?
|
| Health Facilities | 1 | 2025 | 67 | 0.220 |
Why?
|
| Prospective Studies | 3 | 2025 | 6450 | 0.220 |
Why?
|
| Brain | 5 | 2024 | 3164 | 0.210 |
Why?
|
| Infant, Low Birth Weight | 1 | 2024 | 169 | 0.210 |
Why?
|
| Environmental Health | 1 | 2024 | 21 | 0.210 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2025 | 624 | 0.200 |
Why?
|
| Erythrocyte Transfusion | 1 | 2025 | 143 | 0.200 |
Why?
|
| Infant | 6 | 2025 | 13234 | 0.200 |
Why?
|
| Social Justice | 1 | 2024 | 66 | 0.200 |
Why?
|
| Male | 10 | 2025 | 64488 | 0.200 |
Why?
|
| Quality Indicators, Health Care | 1 | 2025 | 240 | 0.190 |
Why?
|
| Quality of Health Care | 1 | 2025 | 409 | 0.180 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 157 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 160 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1266 | 0.160 |
Why?
|
| Maternal Mortality | 1 | 2020 | 78 | 0.160 |
Why?
|
| Child, Preschool | 3 | 2025 | 14945 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2021 | 168 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2021 | 233 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 163 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2024 | 703 | 0.150 |
Why?
|
| Time Factors | 2 | 2025 | 6200 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 351 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 615 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2018 | 65 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 323 | 0.120 |
Why?
|
| Americas | 1 | 2016 | 52 | 0.120 |
Why?
|
| Brazil | 1 | 2016 | 118 | 0.120 |
Why?
|
| Exanthema | 1 | 2017 | 72 | 0.120 |
Why?
|
| United States | 2 | 2025 | 11871 | 0.120 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 211 | 0.120 |
Why?
|
| Fetus | 1 | 2019 | 566 | 0.120 |
Why?
|
| Probiotics | 1 | 2018 | 227 | 0.110 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 38 | 0.110 |
Why?
|
| Fungemia | 1 | 2014 | 22 | 0.110 |
Why?
|
| beta-Glucans | 1 | 2014 | 21 | 0.110 |
Why?
|
| Granulocytes | 1 | 2014 | 69 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2014 | 79 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 502 | 0.110 |
Why?
|
| Fever of Unknown Origin | 1 | 2014 | 44 | 0.110 |
Why?
|
| Immunization, Passive | 1 | 2014 | 123 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2014 | 72 | 0.110 |
Why?
|
| Young Adult | 3 | 2024 | 10010 | 0.110 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 109 | 0.110 |
Why?
|
| Skin | 1 | 2017 | 540 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 31179 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1159 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2564 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1880 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 789 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 410 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2014 | 549 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1226 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 665 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 1169 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2699 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 2204 | 0.070 |
Why?
|
| Child | 2 | 2025 | 26101 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4671 | 0.070 |
Why?
|
| World Health Organization | 1 | 2025 | 115 | 0.060 |
Why?
|
| Hematocrit | 1 | 2025 | 104 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17550 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 1343 | 0.040 |
Why?
|
| Mice | 1 | 2018 | 18243 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 245 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3750 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 484 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 551 | 0.040 |
Why?
|
| Cytokines | 1 | 2025 | 1342 | 0.040 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 111 | 0.040 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 23 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 31 | 0.030 |
Why?
|
| Colombia | 1 | 2018 | 50 | 0.030 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 45 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 99 | 0.030 |
Why?
|
| Blueberry Plants | 1 | 2017 | 6 | 0.030 |
Why?
|
| Animals | 1 | 2018 | 33862 | 0.030 |
Why?
|
| Calcinosis | 1 | 2018 | 180 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1160 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3388 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 302 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1601 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 542 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 551 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2018 | 275 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5176 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 784 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1488 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 973 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2020 | 1060 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10953 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 4021 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4479 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5081 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 20737 | 0.010 |
Why?
|